Delivery Order SPE2DB24D2109-SPE2DB25FHXLP
Award Date 7/18/25
Potential Completion Date 7/21/25
Potential Value $52K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Entresto 49 mg-51 mg tablets (180-count units) with a ceiling value of $11,462.52. This firm fixed-price delivery order, with an ultimate completion date of July 21, 2025, represents a competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency awarded a $3,689.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Entresto 24 mg-26 mg tablets (60-count supply) on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-competitive delivery order was placed against AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be fulfilled at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Entresto 97 mg-103 mg tablets (60-count units) with a ceiling value of $2,242.17. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of July 21, 2025, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical vendor...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Entresto 49 mg-51 mg tablets (60-count units) under a firm fixed-price arrangement. The contract, valued at $5,940.34, carries an ultimate completion date of July 21, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award was competitively procured with no set-aside designation. AmerisourceBergen Drug Corp, a...
- The Defense Logistics Agency awarded a $4,198.26 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Entresto 97 mg-103 mg tablets (180-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 21, 2025, with performance taking place at the vendor's corporate office in Conshohocken, Pennsylvania. Entresto is a combination medication used primarily for heart failure treatment, reflecting the critical pharmaceutical...
- The Defense Logistics Agency awarded a $27,998.28 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Entresto 24 mg-26 mg tablets (60-count packages). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 21, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply the Department of Defense with Entresto 49 mg-51 mg tablets. The contract, valued at $15,060.89, has a period of performance through March 19, 2024. Amerisourcebergen is the prime contractor and there is no set-aside designation for this award. In addition to this specific delivery order,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $41,847.64 contract is for the supply of Entresto 24 mg-26 mg tablets in 180-count bottles, with a period of performance through April 1, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp (a subsidiary of Amerisourcebergen Corporation) to provide Entresto 49 mg-51 mg tablets in 60-count packages. The $14,114.35 award has an ultimate completion date of March 18, 2024. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Entresto 97 mg-103 mg tablets in 60-count packages, with a ceiling value of $41,632.50 and a period of performance through April 2025. The contract is a delivery order, with a firm fixed price pricing type. It is not designated as a set-aside. AmerisourceBergen Drug Corp, headquartered in...